BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

256 related articles for article (PubMed ID: 9773980)

  • 1. Two separate NCoR (nuclear receptor corepressor) interaction domains mediate corepressor action on thyroid hormone response elements.
    Cohen RN; Wondisford FE; Hollenberg AN
    Mol Endocrinol; 1998 Oct; 12(10):1567-81. PubMed ID: 9773980
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Determination of nuclear receptor corepressor interactions with the thyroid hormone receptor.
    Makowski A; Brzostek S; Cohen RN; Hollenberg AN
    Mol Endocrinol; 2003 Feb; 17(2):273-86. PubMed ID: 12554754
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The specificity of interactions between nuclear hormone receptors and corepressors is mediated by distinct amino acid sequences within the interacting domains.
    Cohen RN; Brzostek S; Kim B; Chorev M; Wondisford FE; Hollenberg AN
    Mol Endocrinol; 2001 Jul; 15(7):1049-61. PubMed ID: 11435607
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The nuclear corepressors recognize distinct nuclear receptor complexes.
    Cohen RN; Putney A; Wondisford FE; Hollenberg AN
    Mol Endocrinol; 2000 Jun; 14(6):900-14. PubMed ID: 10847591
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Very strong correlation between dominant negative activities of mutant thyroid hormone receptors and their binding avidity for corepressor SMRT.
    Matsushita A; Misawa H; Andoh S; Natsume H; Nishiyama K; Sasaki S; Nakamura H
    J Endocrinol; 2000 Dec; 167(3):493-503. PubMed ID: 11115777
    [TBL] [Abstract][Full Text] [Related]  

  • 6. DNA binding and interaction with the nuclear receptor corepressor of thyroid hormone receptor are required for ligand-independent stimulation of the mouse preprothyrotropin-releasing hormone gene.
    Satoh T; Monden T; Ishizuka T; Mitsuhashi T; Yamada M; Mori M
    Mol Cell Endocrinol; 1999 Aug; 154(1-2):137-49. PubMed ID: 10509808
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Defective release of corepressor by hinge mutants of the thyroid hormone receptor found in patients with resistance to thyroid hormone.
    Safer JD; Cohen RN; Hollenberg AN; Wondisford FE
    J Biol Chem; 1998 Nov; 273(46):30175-82. PubMed ID: 9804773
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A novel mechanism of thyroid hormone-dependent negative regulation by thyroid hormone receptor, nuclear receptor corepressor (NCoR), and GAGA-binding factor on the rat cD44 promoter.
    Kim SW; Ho SC; Hong SJ; Kim KM; So EC; Christoffolete M; Harney JW
    J Biol Chem; 2005 Apr; 280(15):14545-55. PubMed ID: 15701601
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The interaction of the vitamin D receptor with nuclear receptor corepressors and coactivators.
    Tagami T; Lutz WH; Kumar R; Jameson JL
    Biochem Biophys Res Commun; 1998 Dec; 253(2):358-63. PubMed ID: 9878542
    [TBL] [Abstract][Full Text] [Related]  

  • 10. TR surfaces and conformations required to bind nuclear receptor corepressor.
    Marimuthu A; Feng W; Tagami T; Nguyen H; Jameson JL; Fletterick RJ; Baxter JD; West BL
    Mol Endocrinol; 2002 Feb; 16(2):271-86. PubMed ID: 11818500
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Two receptor interacting domains in the nuclear hormone receptor corepressor RIP13/N-CoR.
    Seol W; Mahon MJ; Lee YK; Moore DD
    Mol Endocrinol; 1996 Dec; 10(12):1646-55. PubMed ID: 8961273
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Nuclear corepressor and silencing mediator of retinoic and thyroid hormone receptors corepressor expression is incompatible with T(3)-dependent TRH regulation.
    Becker N; Seugnet I; Guissouma H; Dupre SM; Demeneix BA
    Endocrinology; 2001 Dec; 142(12):5321-31. PubMed ID: 11713232
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Nuclear receptor corepressor-dependent repression of peroxisome-proliferator-activated receptor delta-mediated transactivation.
    Krogsdam AM; Nielsen CA; Neve S; Holst D; Helledie T; Thomsen B; Bendixen C; Mandrup S; Kristiansen K
    Biochem J; 2002 Apr; 363(Pt 1):157-65. PubMed ID: 11903058
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A novel natural mutation in the thyroid hormone receptor defines a dual functional domain that exchanges nuclear receptor corepressors and coactivators.
    Tagami T; Gu WX; Peairs PT; West BL; Jameson JL
    Mol Endocrinol; 1998 Dec; 12(12):1888-902. PubMed ID: 9849963
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Gene silencing by chicken ovalbumin upstream promoter-transcription factor I (COUP-TFI) is mediated by transcriptional corepressors, nuclear receptor-corepressor (N-CoR) and silencing mediator for retinoic acid receptor and thyroid hormone receptor (SMRT).
    Shibata H; Nawaz Z; Tsai SY; O'Malley BW; Tsai MJ
    Mol Endocrinol; 1997 Jun; 11(6):714-24. PubMed ID: 9171235
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The thyroid hormone receptor recruits NCoR via widely spaced receptor-interacting domains.
    Astapova I; Dordek MF; Hollenberg AN
    Mol Cell Endocrinol; 2009 Aug; 307(1-2):83-8. PubMed ID: 19524130
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Inhibition of the dihydrotestosterone-activated androgen receptor by nuclear receptor corepressor.
    Cheng S; Brzostek S; Lee SR; Hollenberg AN; Balk SP
    Mol Endocrinol; 2002 Jul; 16(7):1492-501. PubMed ID: 12089345
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Transcriptional silencing by unliganded thyroid hormone receptor beta requires a soluble corepressor that interacts with the ligand-binding domain of the receptor.
    Tong GX; Jeyakumar M; Tanen MR; Bagchi MK
    Mol Cell Biol; 1996 May; 16(5):1909-20. PubMed ID: 8628257
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Characterization of receptor interaction and transcriptional repression by the corepressor SMRT.
    Li H; Leo C; Schroen DJ; Chen JD
    Mol Endocrinol; 1997 Dec; 11(13):2025-37. PubMed ID: 9415406
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Pathological Interactions Between Mutant Thyroid Hormone Receptors and Corepressors and Their Modulation by a Thyroid Hormone Analogue with Therapeutic Potential.
    Harrus D; Déméné H; Vasquez E; Boulahtouf A; Germain P; Figueira AC; Privalsky ML; Bourguet W; le Maire A
    Thyroid; 2018 Dec; 28(12):1708-1722. PubMed ID: 30235988
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.